Suppr超能文献

乳腺癌患者接受 2 期扩张器/植入物重建的放射方式(质子/光子)、时机和并发症发生率。

Radiation Modality (Proton/Photon), Timing, and Complication Rates in Patients With Breast Cancer Receiving 2-Stages Expander/Implant Reconstruction.

机构信息

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachussetts; Current Affiliation: Department of Radiation Oncology, Northwestern University Memorial Hospital, Chicago, Illinois.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachussetts.

出版信息

Pract Radiat Oncol. 2022 Nov-Dec;12(6):475-486. doi: 10.1016/j.prro.2022.05.017. Epub 2022 Jun 27.

Abstract

PURPOSE

Our purpose is to explore the effect of postmastectomy radiation therapy (PMRT) modality and timing on complication rates in breast cancer patients receiving immediate 2-stages expander/implant.

METHODS AND MATERIALS

We reviewed the charts of 661 patients who underwent immediate 2-stages expander/implant with/without PMRT at our institution from 2000 to 2019. Patients were divided into 3 cohorts: no radiation, PMRT to expanders (RTE), and PMRT to implants after expander exchange (RTI). PMRT was delivered either with 3-dimensional conformal photon with or without chest wall boost (CWB) or proton therapy. Reconstruction complications were defined as infection/necrosis requiring debridement, capsular-contracture requiring capsulotomy, and reconstruction failure requiring prothesis removal. Logistic regression and Cox models were used to assess the effect of different radiation therapy modalities on complication rates and local control.

RESULTS

Among 661 patients, 309 (46.7%) received PMRT, 220 of the 309 (71.2%) received RTE before exchange, and 89 (28.8%) received RTI after exchange. Seventeen out of 309 (5.5%) patients received proton therapy. The complications among RTE versus RTI cohorts were 22.7% versus 15.7% for infection/necrosis, 13.6% versus 19.1% for capsular-contracture, and 39.5% versus 31.5% for overall reconstruction failure, respectively. Among proton patients, 8/17 (47%) developed capsular contracture compared with 16.4% (24/146) and 10.3% (15/146) in CWB and non-CWB groups, respectively. Adjusted multivariable analysis showed no significant difference between RTI and RTE in terms of infection/necrosis and capsular contracture. Yet, RTE significantly increased overall reconstruction failure compared with RTI (39.5% vs 31.5%; odds ratio [OR], 2.11; P = .02). Protons significantly increased capsular contracture compared with both CWB and non-CWB groups (OR, 5.4; P = .01 and OR, 10.9; P < .001, respectively). Moreover, proton significantly increased overall reconstruction failure. The 5-year local control rates were 95.3% and 97.7% for RTE and RTI, respectively (hazard ratio, 1.2; P = .7).

CONCLUSIONS

Early radiation to the expander before the exchange to implant significantly increased overall reconstruction failure without improving local control. Protons significantly increased capsular contracture rates and overall reconstruction failure leading to more revision surgeries.

摘要

目的

本研究旨在探讨乳腺癌患者接受即刻 2 期扩张器/植入物治疗时,乳房切除术(PMRT)方式和时机对并发症发生率的影响。

方法和材料

我们回顾了 2000 年至 2019 年在我院接受即刻 2 期扩张器/植入物治疗的 661 例患者的病历。患者被分为 3 组:无放疗组、PMRT 至扩张器组(RTE)和 PMRT 至扩张器更换后植入物组(RTI)。PMRT 采用三维适形光子放疗,或联合或不联合胸壁加量放疗(CWB),或质子治疗。重建并发症定义为需要清创的感染/坏死、需要切开松解的包膜挛缩和需要去除假体的重建失败。采用 logistic 回归和 Cox 模型评估不同放疗方式对并发症发生率和局部控制的影响。

结果

在 661 例患者中,309 例(46.7%)接受了 PMRT,其中 220 例(71.2%)在交换前接受了 RTE,89 例(28.8%)在交换后接受了 RTI。309 例患者中有 17 例(5.5%)接受了质子治疗。RTE 组与 RTI 组的并发症发生率分别为感染/坏死 22.7%比 15.7%,包膜挛缩 13.6%比 19.1%,整体重建失败 39.5%比 31.5%。在质子治疗患者中,8/17(47%)发生包膜挛缩,而 CWB 组和非 CWB 组分别为 16.4%(24/146)和 10.3%(15/146)。多变量调整分析显示,RTI 与 RTE 在感染/坏死和包膜挛缩方面无显著差异。然而,RTE 与 RTI 相比,整体重建失败显著增加(39.5%比 31.5%;比值比[OR],2.11;P=0.02)。与 CWB 和非 CWB 组相比,质子治疗显著增加了包膜挛缩(OR,5.4;P=0.01 和 OR,10.9;P<0.001)。此外,质子治疗还显著增加了整体重建失败。RTE 和 RTI 的 5 年局部控制率分别为 95.3%和 97.7%(风险比,1.2;P=0.7)。

结论

在更换为植入物之前,早期对扩张器进行放疗显著增加了整体重建失败的风险,而没有改善局部控制。质子治疗显著增加了包膜挛缩的发生率和整体重建失败的风险,导致更多的修复手术。

相似文献

4
The Impact of Chest Wall Boost on Reconstruction Complications and Local Control in Patients Treated for Breast Cancer.
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):155-164. doi: 10.1016/j.ijrobp.2019.04.027. Epub 2019 May 2.
5
Post-mastectomy adjuvant radiotherapy for direct-to-implant and two-stage implant-based breast reconstruction: A meta-analysis.
J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3030-3040. doi: 10.1016/j.bjps.2022.06.063. Epub 2022 Jun 22.
6
Postmastectomy Radiation Therapy and Two-Stage Implant-Based Breast Reconstruction: Is There a Better Time to Irradiate?
Plast Reconstr Surg. 2016 Oct;138(4):761-769. doi: 10.1097/PRS.0000000000002534.
8
Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy.
Breast Cancer Res Treat. 2020 Aug;183(1):127-136. doi: 10.1007/s10549-020-05747-7. Epub 2020 Jun 30.
9
A meta-analysis of implant-based breast reconstruction and timing of adjuvant radiation therapy.
J Surg Res. 2017 Oct;218:108-116. doi: 10.1016/j.jss.2017.05.072. Epub 2017 Jun 15.
10
ADM-Assisted Direct-to-Implant Prepectoral Breast Reconstruction in Postmastectomy Radiation Therapy Setting: Long-Term Results.
Clin Breast Cancer. 2023 Oct;23(7):704-711. doi: 10.1016/j.clbc.2023.06.011. Epub 2023 Jul 1.

引用本文的文献

1
Immediate 2-Stage breast reconstruction outcomes after proton or photon postmastectomy radiotherapy.
Clin Transl Radiat Oncol. 2025 Jul 13;54:101015. doi: 10.1016/j.ctro.2025.101015. eCollection 2025 Sep.
2
Breast cancer implant reconstructive surgery and radiotherapy: a retrospective analysis of medical records.
Ann Surg Treat Res. 2025 May;108(5):295-301. doi: 10.4174/astr.2025.108.5.295. Epub 2025 Apr 28.
3
5
Postmastectomy radiotherapy in breast reconstruction: Current controversies and trends.
Cancer Innov. 2024 Jan 7;3(1):e104. doi: 10.1002/cai2.104. eCollection 2024 Feb.
7
Breast Reconstruction Complications After Postmastectomy Proton Radiation Therapy for Breast Cancer.
Adv Radiat Oncol. 2023 Oct 14;9(3):101385. doi: 10.1016/j.adro.2023.101385. eCollection 2024 Mar.
8
Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection.
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241234788. doi: 10.1177/15330338241234788.

本文引用的文献

2
The Baker Classification for Capsular Contracture in Breast Implant Surgery Is Unreliable as a Diagnostic Tool.
Plast Reconstr Surg. 2020 Nov;146(5):956-962. doi: 10.1097/PRS.0000000000007238.
3
Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy.
Breast Cancer Res Treat. 2020 Aug;183(1):127-136. doi: 10.1007/s10549-020-05747-7. Epub 2020 Jun 30.
4
Integration of Breast Reconstruction and Postmastectomy Radiotherapy.
J Clin Oncol. 2020 Jul 10;38(20):2329-2340. doi: 10.1200/JCO.19.02850. Epub 2020 May 22.
6
Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives.
Plast Reconstr Surg. 2020 Apr;145(4):865-876. doi: 10.1097/PRS.0000000000006627.
8
The Impact of Chest Wall Boost on Reconstruction Complications and Local Control in Patients Treated for Breast Cancer.
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):155-164. doi: 10.1016/j.ijrobp.2019.04.027. Epub 2019 May 2.
9
Radiotherapy in the setting of breast reconstruction: types, techniques, and timing.
Lancet Oncol. 2017 Dec;18(12):e742-e753. doi: 10.1016/S1470-2045(17)30617-4.
10
Current Trends in Postmastectomy Breast Reconstruction.
Plast Reconstr Surg. 2017 Nov;140(5S Advances in Breast Reconstruction):7S-13S. doi: 10.1097/PRS.0000000000003941.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验